About Mustafa Nevzat İlaç
Mustafa Nevzat İlaç is a Healthcare company based in Istanbul (Turkey) founded in 1923 by Mustafa Nevzat Pysak, and was acquired by Amgen in April 2012. Manufacturer of active pharmaceutical ingredients and finished dosage forms. Mustafa Nevzat İlaç offers products and services including Niclonex, MP-204, MP-303, and MP-4 Series. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its legal entity is Mustafa Nevzat İlaç San. A.Ş.
Company details
Founded in 1923, MN Pharmaceuticals operates as a key player in the Turkish pharmaceutical sector, focusing on active pharmaceutical ingredients and finished dosage forms. Production occurs across dedicated facilities in Istanbul, including units for beta-lactam antibiotics, injectables, oral forms, and oncology products. Approvals from the FDA and EMEA have been obtained for API and dosage forms, with operations centered on parenteral and specialized drug manufacturing.
Products & Services of Mustafa Nevzat İlaç
Mustafa Nevzat İlaç offers a comprehensive portfolio of products and services, including Niclonex, MP-204, MP-303, and MP-4 Series.
Treats Covid-19 by inhibiting viral replication.
Targets viral skin infections like HPV.
Addresses non-melanoma skin cancers.
Enhances NSAID drugs for faster pain management.
Investors in Mustafa Nevzat İlaç
Mustafa Nevzat İlaç has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Amgen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of pharmaceutical products for treating multiple diseases | 1980 | amgen.com | Thousand Oaks, United States |
Investor details for Mustafa Nevzat İlaç
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mustafa Nevzat İlaç
1 people are tracked at Mustafa Nevzat İlaç (1 in leadership).
| Name | Role | Group |
|---|---|---|
Mustafa Nevzat Pysak | Founder | Leadership |
Complete people profiles for Mustafa Nevzat İlaç
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mustafa Nevzat İlaç
2 dated milestones of Mustafa Nevzat İlaç across 89 years, from founding to its latest funding, stage changes and deals.
- Founded Mustafa Nevzat İlaç is founded.
- Exit Acquired by Amgen.
Web traffic of Mustafa Nevzat İlaç
Websites that share an audience with Mustafa Nevzat İlaç (mn.com.tr).
Websites whose visitors overlap most with Mustafa Nevzat İlaç. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nobel.com.tr | 100% | 82.9K | #384,871 | View details | |
abdiibrahim.com.tr | abdiibrahim.com.tr | 99% | #180,526 | – | |
| santafarma.com.tr | 96% | #332,566 | View details | ||
iegm.gov.tr | iegm.gov.tr | 93% | – | ||
aliraif.com.tr | aliraif.com.tr | 91% | #999,360 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 17 similar websites and full traffic analytics for Mustafa Nevzat İlaç
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 17 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mustafa Nevzat İlaç
Complete news archive for Mustafa Nevzat İlaç
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mustafa Nevzat İlaç
Mustafa Nevzat İlaç was founded in 1923.
Mustafa Nevzat İlaç is headquartered in Istanbul, Turkey.
Founded in 1923, MN Pharmaceuticals operates as a key player in the Turkish pharmaceutical sector, focusing on active pharmaceutical ingredients and finished dosage forms. Production occurs across dedicated facilities in Istanbul, including units for beta-lactam antibiotics, injectables, oral forms, and oncology products. Approvals from the FDA and EMEA have been obtained for API and dosage forms, with operations centered on parenteral and specialized drug manufacturing.
Mustafa Nevzat İlaç offers Niclonex, MP-204, MP-303, and MP-4 Series.
Mustafa Nevzat İlaç has 1 investor. Key investors include Amgen.
Mustafa Nevzat İlaç operates through Mustafa Nevzat İlaç San. A.Ş..
Yes. Mustafa Nevzat İlaç was acquired by Amgen in April 2012.